Arix Bioscience Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
41
- Portfolio
-
1
- Exits
-
28
Arix Bioscience General Information
Company Description
Founded in 2015, Arix Bioscience was a venture capital firm based in London, United Kingdom. The firm preferred to invest in seed-stage companies, preclinical and clinical-stage assets, and private or public companies operating across biotech, healthcare, and life science sectors.
Business Details
Website
www.arix-bioscience.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Duke Street House
- 50 Duke Street
- London W1K 6JL
- England, United Kingdom
Arix Bioscience Investments & Acquisitions (41)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Evommune | 28-Jun-2023 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Ensoma | 16-May-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Harpoon Therapeutics | 27-Mar-2023 | Drug Discovery | Generating Revenue | |||
| Disc Medicine | 31-Dec-2022 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Sorriso Pharmaceuticals | 22-Dec-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Depixus | 15-Dec-2021 | Biotechnology | Generating Revenue | |||
| Disc Medicine | 02-Sep-2021 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Artios | 27-Jul-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Pyxis Oncology | 30-Mar-2021 | Early Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
| Aura Biosciences | 22-Mar-2021 | Later Stage VC | Drug Discovery | Generating Revenue/Not Profitable |
Arix Bioscience Exits (28)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Artios | 17-Nov-2025 | Later Stage VC | |
| Evommune | 06-Nov-2025 | ||
| Ensoma | 22-Sep-2025 | ||
| Depixus | 31-Dec-2024 | ||
| BioMotiv | 07-Aug-2024 | ||
| Sorriso Pharmaceuticals | 01-May-2024 | ||
| STipe Therapeutics | 01-Oct-2023 | ||
| Enliven Therapeutics | 23-Feb-2023 | ||
| Twelve bio | 05-Jan-2023 | Merger/Acquisition | |
| Disc Medicine | 30-Dec-2022 | Reverse Merger |
Arix Bioscience Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Arix Bioscience Co-Investors (22)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| SymBiosis (Bentonville) | 2 |
|
|
||
| 5AM Ventures |
|
|
|||
| Andera Partners |
|
|
|||
| EQT Life Sciences |
|
|
|||
| Takeda Ventures |
|
|
Arix Bioscience Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Arix Capital Management | Cardiff, United Kingdom | 2012 |
Arix Bioscience FAQs
-
What is Arix Bioscience?
Founded in 2015, Arix Bioscience was a venture capital firm based in London, United Kingdom.
-
When was Arix Bioscience founded?
Arix Bioscience was founded in 2015.
-
Where is Arix Bioscience headquartered?
Arix Bioscience is headquartered in London, United Kingdom.
-
What is Arix Bioscience's total asset value?
Arix Bioscience has around in total assets under management.
-
How many investments has Arix Bioscience made?
Arix Bioscience has made 41 investments.
-
What has Arix Bioscience invested in?
Arix Bioscience has made numerous investments in companies like Evommune, Ensoma, and Harpoon Therapeutics within the Drug Discovery industry.
-
What has Arix Bioscience invested in recently?
Arix Bioscience's latest investment was on 28-Jun-2023 in Evommune, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
